Mayinglong Pharmaceutical Group Co.,Ltd — Investor Relations & Filings
About Mayinglong Pharmaceutical Group Co.,Ltd
Mayinglong Pharmaceutical Group Co.,Ltd. is a long-established enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Founded in 1582, the company is widely recognized for its expertise in proctology, maintaining a dominant market position with its signature hemorrhoid ointments and suppositories. Its product portfolio also includes ophthalmic preparations, dermatological treatments, and gastrointestinal medicines. The company integrates traditional medicinal formulas with modern manufacturing technologies to provide healthcare solutions. Beyond pharmaceuticals, Mayinglong has expanded into healthcare services, including specialized hospitals and personal care products, focusing on the integration of clinical treatment and health management.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 马应龙2025年内部控制评价报告 | 2026-04-24 | Chinese | |
| 马应龙2026年第一季度报告 | 2026-04-24 | Chinese | |
| 马应龙关于为子公司提供担保额度的公告 | 2026-04-24 | Chinese | |
| 马应龙2025年度独立董事述职报告（梅之南） | 2026-04-24 | Chinese | |
| 马应龙董事会关于独立董事独立性情况的专项意见 | 2026-04-24 | Chinese | |
| 马应龙董事、高级管理人员薪酬管理制度 | 2026-04-24 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 41847673 | 马应龙2025年内部控制评价报告 | 2026-04-24 | Chinese | ||
| 41847663 | 马应龙2026年第一季度报告 | 2026-04-24 | Chinese | ||
| 41847640 | 马应龙关于为子公司提供担保额度的公告 | 2026-04-24 | Chinese | ||
| 41847635 | 马应龙2025年度独立董事述职报告（梅之南） | 2026-04-24 | Chinese | ||
| 41847633 | 马应龙董事会关于独立董事独立性情况的专项意见 | 2026-04-24 | Chinese | ||
| 41847621 | 马应龙董事、高级管理人员薪酬管理制度 | 2026-04-24 | Chinese | ||
| 41847610 | 马应龙2025年度会计师事务所履职情况评估报告 | 2026-04-24 | Chinese | ||
| 41847603 | 马应龙2025年度审计报告 | 2026-04-24 | Chinese | ||
| 41846754 | 马应龙2025年年度报告 | 2026-04-24 | Chinese | ||
| 41846752 | 马应龙2025年度非经营性资金占用及其他关联资金往来情况汇总表的专项审核报告 | 2026-04-24 | Chinese | ||
| 41846740 | 马应龙关于董事会延迟换届的提示性公告 | 2026-04-24 | Chinese | ||
| 41846731 | 马应龙关于2025年度利润分配方案的公告 | 2026-04-24 | Chinese | ||
| 41846726 | 马应龙2025年度环境、社会和治理（ESG）报告 | 2026-04-24 | Chinese | ||
| 41846293 | 马应龙董事会审计委员会对2025年度会计师事务所履行监督职责情况报告 | 2026-04-24 | Chinese | ||
| 41846291 | 马应龙关于控股子公司转让下属控股公司股权的公告 | 2026-03-30 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Mayinglong Pharmaceutical Group Co.,Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57144/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57144 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57144 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57144 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57144}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Mayinglong Pharmaceutical Group Co.,Ltd (id: 57144)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.